Electrical Stimulation of the Optic Nerve in Patients With Glaucoma.
Enrolling by invitation · Not applicable
Conditions studied: Glaucoma
In brief
The goal of this observational study is to evaluate electrical stimulation of the optic nerve with the Eyetronic Nextwave System device as a possible treatment for glaucoma. The main question it aims to answer is: Could this therapy be an option to counteract the loss of visual field seen in glaucoma and thus delay the progression of the disease? Participants will have approximately 14-18 study visits during 12 months including 10 visits for the electrical stimulation treatment. The treatment involves electrically stimulating the optic nerve by an external approach via the facial skin.
Key facts
- Study ID
- NCT06693882
- Run by
- Glaucoma Center of San Francisco
- People needed
- 50
- Starts
- 2025-01-01
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2024-11-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects 18 years or older who have glaucoma
- Humphrey visual field mean deviation (MD) values between - 6 dB and -20 dB
You may not qualify if…
- Age < 18 years
- Implanted electronic devices
- Metallic artifacts in the head (except dentures)
- Migraine
- Epilepsy
- Brain tumor
- Pregnancy
- Breastfeeding patients
- Uncontrolled intraocular pressure (IOP)
- IOP lowering medication started less than six months before enrollment
- Any intraocular surgery less than 6 months before enrollment
- Arterial hypertension without appropriate treatment
- Acute retinal hemorrhage
Where it is running
- Glaucoma Center of San Francisco — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.